Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain
Systemic inflammation prevalence is high among patients with ASCVD in Spain, especially among patients with comorbid CKD. Therapeutic strategies focused on targeting systemic inflammation may have beneficial effects in reducing the burden of ASCVD.
Authors
- Artak Khachatryan (ORCID: https://orcid.org/0000-0003-3888-2347)
- Gaëlle Gusto
- Pierre Johansen (ORCID: https://orcid.org/0000-0002-6287-7508)
- Giancarlo Pesce (ORCID: https://orcid.org/0000-0003-4925-6325)
- Aleix Cases (ORCID: https://orcid.org/0000-0002-6962-8184)
- Jelena Vukmirica
- Bernabe Lopez-Ledesma
Institutions
- Novo Nordisk (Denmark) (DK)
- Hospital Clínic de Barcelona (ES)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-03-04
- DOI
- https://doi.org/10.3389/fcvm.2025.1538466
- Citations
- 4
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.19